Highlights Verisante Technology Inc.

Equities

VRSEF

CA92346G2036

Delayed OTC Markets Other stock markets 19:24:47 03/05/2024 BST			5-day change	1st Jan Change
0.0023 ^USD	0.00%		0.00%	+22,900.00%

04-20	Verisante Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-30	Verisante Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Verisante Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-20	CI
Verisante Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
Verisante Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	18/10/23	CI
Verisante Technology Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/08/23	CI
Verisante Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Verisante Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	20/03/23	CI
Verisante Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	18/11/22	CI
Verisante Technology Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	01/08/22	CI
Reverse Split: 1 of 10	22/06/22	FA
Verisante Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	30/05/22	CI
Verisante Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	07/02/22	CI
SIM Co. Ltd. cancelled the definitive agreement to acquire Verisante Technology Inc. from Thomas Braun and others in a reverse merger transaction.	13/01/20	CI
SIM Co. Ltd. entered into a letter of intent to acquire Verisante Technology Inc. from Thomas Braun and others in a reverse merger transaction.	08/07/18	CI
Verisante Technology Inc. Reports Earnings Results for the Second Quarter of 2017	30/08/17	CI
Verisante Technology, Inc. Provides Operational Update	23/12/15	CI
Verisante Technology, Inc. Enters Amended Licensing Agreement with the BC Cancer Agency	09/07/15	CI
Verisante Technology, Inc. Obtains Mexican Approval to Market and Sell Aura	12/03/15	CI
Verisante Technology, Inc. Enters into Collaboration with BC Cancer Agency and Imperial College Healthcare NHS Trust to Develop New Application for its Exclusively Licensed Platform Technology	13/01/15	CI
Verisante Technology, Inc. Initiates Communications with FDA in the United States for the Approval of Aura	01/10/14	CI
Verisante Technology Forms Joint Venture with Undisclosed Chinese Partner	30/09/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Verisante Technology Inc.

Equities

VRSEF

CA92346G2036

Highlights

Filters